The Effect of Pulsed Electromagnetic Field Therapy on Patients With Low Back Pain
for
Low Back Pain
Location: Bridgeport CT
Sponsor: University of Bridgeport
Sex: All
Age: 18 - 70
Code: NCT03053375
Recruiting
Endogenous Opioid Response to Injections
for
Low Back Pain, Zygapophyseal Joint Arthritis
Location: Nashville TN
Sponsor: Middle Tennessee Research Institute
Sex: All
Age: 18+
Code: NCT06666621
Recruiting
A Bowel Management Program (Retrograde Rectal Enema) for the Treatment of Low Anterior Resection Syndrome in Rectal Cancer Patients
for
Low Anterior Resection Syndrome, Rectal Carcinoma
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT06424522
Recruiting
PerQdisc Traditional Feasibility Trial.
for
Discogenic Low Back Pain
Location: Carmel IN, Shreveport LA, Coeur d'Alene ID,
Sponsor: Spinal Stabilization Technologies
Sex: All
Age: 22 - 70
Code: NCT06860867
Recruiting
Dry Needling Effects on Cortical Excitability
for
Low Back Pain
Location: Dallas TX
Sponsor: Texas Woman's University
Sex: All
Age: 18 - 65
Code: NCT05111691
Recruiting
Interested in new myelodysplastic syndromes trials?
Get alerts for new trials in your area by subscribing now
Improving Health for Patients With Chronic Low Back Pain in Rural Communities Through Telerehabilitation
for
Chronic Low-back Pain
Location: Salisbury MD, Baltimore MD
Sponsor: Johns Hopkins University
Sex: All
Age: 18+
Code: NCT06471920
Recruiting
An Efficacy Study of Exercise Rehabilitation on Pain and Disability for Patients With Non-specific Low Back Pain
for
Low Back Pain, Mechanical
Location: Calgary
Sponsor: Running Injury Clinic
Sex: All
Age: 18 - 65
Code: NCT01567566
Recruiting
Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm
for
Recurrent Acute Myeloid Leukemia,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT04140487
Phase1, Phase2, Recruiting
Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes
for
Myelodysplastic/Myeloproliferative Neoplasm,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center
Sex: All
Age: 18 - 70+
Code: NCT07228624
Phase2, Recruiting
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
for
Leukemia
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 60+
Code: NCT01515527
Phase2, Recruiting
Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, Myeloproliferative Neoplasm/Myelodysplastic Syndrome Overlap or High Risk Chronic Myelomonocytic Leukemia
for
Atypical Chronic Myeloid Leukemia,
Location: Columbus OH
Sponsor: Uma Borate
Sex: All
Age: 18+
Code: NCT06523556
Phase1, Phase2, Recruiting
Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia and Myelodysplastic Syndrome/MPN Overlap Neoplasms
for
Recurrent Chronic Myelomonocytic Leukemia,
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT05549661
Phase1, Recruiting
CER-1236 in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myelofibrosis (MF)
Location: Nashville TN, Houston TX, Denver CO, Sacramento CA
Sponsor: CERo Therapeutics Holdings, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06834282
Phase1, Recruiting
New
Electronic Health Record Augmented LDL-Cholesterol Optimization and Control Via Active Lipid Engagement (EHR-LOCALE): A Quality Improvement Implementation Study
MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)
for
Polycythemia Vera, ET (Essential Thrombocythemia),
Location: New York NY, Chicago IL
Sponsor: MPN Research Foundation
Sex: All
Age: 18+
Code: NCT07362225
Recruiting
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
for
Non Hodgkin Lymphoma, Richter Transformation, Multiple Myeloma,
Location: Boston MA, Chapel Hill NC, Columbus OH, Cincinnati OH,
Sponsor: Newave Pharmaceutical Inc
Sex: All
Age: 13+
Code: NCT04771572
Phase1, Recruiting
Familial Investigations of Childhood Cancer Predisposition